News

Eurocine Vaccines presentation på Småbolagsdagarna i Stockholm

Eurocine Vaccines presenterade bolaget, utvecklingen av ett klamydiavaccin och den mycket intressanta nytillkomna vaccinkandidaten mot Herpes simplexvirus typ 2 på Småbolagsdagarna i Stockholm den 15…

Eurocine Vaccines presenterar på Småbolagsdagarna i Stockholm idag onsdag den 15 juni 2022

Eurocine Vaccines kommer att presentera bolaget, utvecklingen av ett klamydiavaccin och den mycket intressanta nytillkomna vaccinkandidaten mot Herpes simplexvirus typ 2 på Småbolagsdagarna i Stockholm,…

Eurocine Vaccines expands its portfolio with a therapeutic HSV-2 vaccine candidate

Eurocine Vaccines AB ("Eurocine Vaccines") hereby announces that the company has entered into a research and collaboration agreement with Redbiotec AG ("Redbiotec"). The agreement gives…

Calendar

BIO-Europe

BIO-Europe has grown into Europe’s largest partnering conference serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain have come togetherRead…

Biotechgate Digital Partnering

Eurocine Vaccines, a dedicated and returning participant, will join the Biotechgate Digital Partnering to meet with people in the vaccine area, both new connections and already establishedRead…